China NMPA Product Recall - Metal intramedullary nail

Zimmer GmbH, a medical device manufacturer based in Switzerland, initiated a voluntary Class III recall for its Metallic Intramedullary Nail product. This significant action was publicly reported on May 21, 2021, by Zimmer (Shanghai) Medical International Trading Co., Ltd. to the National Medical Products Administration (NMPA), China's primary regulatory body for medical devices. The recall, registered under Certificate No.: 20143135679, stemmed from a critical manufacturing issue: a mixed batch involving specific models and batches of the Metallic Intramedullary Nail with varying CCD angles of 1300 and 1250. This type of product mix-up poses a potential risk as it could lead to the incorrect device being used during surgical procedures, thereby compromising patient safety and the intended therapeutic outcome. In response to this identified product discrepancy, Zimmer GmbH undertook a voluntary recall, categorizing it as Class III, indicating a situation where the use of or exposure to a violative product is not likely to cause adverse health consequences. The company's prompt action, reported through its local subsidiary, highlights its adherence to regulatory responsibilities and commitment to product quality and patient well-being under the NMPA's regulatory framework. Detailed specifics concerning the affected product models, specifications, and batch numbers are documented in the official "Medical Device Recall Event Report Form." This recall ensures the removal of potentially mislabeled or incorrect products from the market, mitigating future risks and maintaining confidence in the supply chain of critical medical devices.